Argiles G, Mulet N, Valladares-Ayerbes M, Vieitez JM, et al. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). Eur J Cancer 2022;177:154-163.
PMID: 36335783